| |
MAGE-3 (271-279), human  |
|
|
| Cat. No. |
Size |
Price |
Figures |
|---|
RP10641-1 mg
| 1 mg | $ 38.00 | MSDS: 20080822030446 (PDF)
STRUCTURE:
Zoom
References:
- Valmori D, Lienard D et al. Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocyte antigen-A2 melanoma patients. Cancer Res. Feb 1997;57(4):735-41.
- Zhang Y, Sun Z et al. Monitoring of anti-vaccine CD4 T cell frequencies in melanoma patients vaccinated with a MAGE-3 protein. J Immunol. Feb 2005;174(4):2404-11.
|
|---|
| Full Name | |
| Alias |
MAGE3 Antigen |
Sequence
(one-letter code) |
FLWGPRALV | Sequence
(three-letter code) | {PHE}{LEU}{TRP}{GLY}{PRO}{ARG}{ALA}{LEU}{VAL} |
|---|
| Description | MAGE-3 gene is a member of a multigene family that is selectively expressed by subsets of different human tumor types, including malignant melanoma. |
|---|
| Formula | C53H79N13O10 |
|---|
| M.W. | 1058.3 |
|---|
| Purity | > 95% |
|---|
| Storage | Store at -20°C. |
|
